"Estradiol Dehydrogenases" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Enzymes that catalyze the oxidation of estradiol at the 17-hydroxyl group in the presence of NAD+ or NADP+ to yield estrone and NADH or NADPH. The 17-hydroxyl group can be in the alpha- or beta-configuration. EC 1.1.1.62
| Descriptor ID |
D004960
|
| MeSH Number(s) |
D08.811.682.047.436.375.280
|
| Concept/Terms |
Estradiol Dehydrogenases- Estradiol Dehydrogenases
- Dehydrogenases, Estradiol
- Estradiol Dehydrogenase
- Dehydrogenase, Estradiol
Estradiol 17 beta-Dehydrogenase- Estradiol 17 beta-Dehydrogenase
- 17 beta-Dehydrogenase, Estradiol
- Estradiol 17 beta Dehydrogenase
- 17 beta-Estradiol Dehydrogenase
- 17 beta Estradiol Dehydrogenase
- Dehydrogenase, 17 beta-Estradiol
|
Below are MeSH descriptors whose meaning is more general than "Estradiol Dehydrogenases".
Below are MeSH descriptors whose meaning is more specific than "Estradiol Dehydrogenases".
This graph shows the total number of publications written about "Estradiol Dehydrogenases" by people in this website by year, and whether "Estradiol Dehydrogenases" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2015 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Estradiol Dehydrogenases" by people in Profiles.
-
The prognostic impact of lipid biosynthesis-associated markers, HSD17B2 and HMGCS2, in rectal cancer treated with neoadjuvant concurrent chemoradiotherapy. Tumour Biol. 2015 Sep; 36(10):7675-83.